Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis. |
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
Ka7gQzMPMyLRPY6R
Listen
